0001209191-20-065508.txt : 20201230 0001209191-20-065508.hdr.sgml : 20201230 20201230161433 ACCESSION NUMBER: 0001209191-20-065508 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201228 FILED AS OF DATE: 20201230 DATE AS OF CHANGE: 20201230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Armstrong Christopher R CENTRAL INDEX KEY: 0001775448 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38467 FILM NUMBER: 201426019 MAIL ADDRESS: STREET 1: C/O CERIDIAN HCM HOLDING INC. STREET 2: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ceridian HCM Holding Inc. CENTRAL INDEX KEY: 0001725057 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 463231686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 BUSINESS PHONE: 952-853-8100 MAIL ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-28 0 0001725057 Ceridian HCM Holding Inc. CDAY 0001775448 Armstrong Christopher R C/O CERIDIAN HCM HOLDING INC. 3311 E. OLD SHAKOPEE ROAD MINNEAPOLIS MN 55425 0 1 0 0 EVP, Chief Customer Officer Common Stock 2020-12-28 4 M 0 6321 16.74 A 75164 D Common Stock 2020-12-28 4 M 0 8720 17.20 A 83884 D Common Stock 2020-12-28 4 M 0 16983 22.00 A 100867 D Common Stock 2020-12-28 4 S 0 17979 106.96 D 82888 D Common Stock 2020-12-28 4 S 0 6865 107.75 D 76023 D Common Stock 2020-12-28 4 S 0 6123 109.44 D 69900 D Common Stock 2020-12-28 4 S 0 800 110.28 D 69100 D Common Stock 2020-12-28 4 S 0 257 111.06 D 68843 D Option (right to buy) 16.74 2020-12-28 4 M 0 6321 D 2026-06-01 Common Stock 6321 0 D Option (right to buy) 17.20 2020-12-28 4 M 0 8720 D 2027-04-27 Common Stock 8720 2907 D Option (right to buy) 22.00 2020-12-28 4 M 0 16983 D 2028-04-25 Common Stock 16983 50952 D Option (right to buy) 44.91 2029-02-08 Common Stock 50000 50000 D Option (right to buy) 44.91 2029-02-08 Common Stock 2301 2301 D Option (right to buy) 65.26 2030-05-08 Common Stock 107244 107244 D Performance Units 2021-03-01 Common Stock 3382 3382 D The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.426 to $107.41 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.445 to $108.065 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.93 to $109.92 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.95 to $110.53 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 18,313 shares of common stock, (ii) 37,500 shares issuable pursuant to Restricted Stock Units, granted on February 8, 2019, that vest in three annual installments beginning on February 8, 2021, (ii) 1,538 shares that are issuable pursuant to Restricted Stock Units, granted on February 28, 2020, that vest in three annual installments beginning on February 28, 2021, and (iv) 11,492 shares that are issuable pursuant to Restricted Stock Units, granted on May 8, 2020, that vest in three annual installments beginning on May 8, 2021. Fully vested and exercisable. Not Applicable Consists of 33,967 vested and exercisable options as of April 25, 2020, of which 16,983 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 33,968 options that vest and become exercisable in two annual installments beginning on April 25, 2021. Consists of 12,500 vested and exercisable options as of February 8, 2020 and 37,500 options that vest and become exercisable in three annual installments beginning on February 8, 2021. Consists of 575 vested and exercisable options as of February 8, 2020 and 1,726 options that vest and become exercisable in three annual installments beginning on February 8, 2021. These options vest and become exercisable in four annual installments beginning on May 8, 2021. Each performance unit, granted on February 28, 2020, represents a contingent right to receive up to 1.25 shares of Common Stock. The performance units vest upon satisfaction of Cloud Revenue and Adjusted EBITDA margin targets under the Company's 2020 Management Incentive Plan. For Christopher Armstrong, pursuant to the Power of Attorney previously filed. /s/ William E. McDonald, attorney-in-fact 2020-12-30